Literature DB >> 5015047

Cell-mediated immune responses in chronic liver diseases.

M G Smith, P L Golding, A L Eddleston, C G Mitchell, A Kemp, R Williams.   

Abstract

Studies of the cell-mediated response to liver antigens, using the leucocyte migration test, in 163 patients with various liver disorders showed that abnormal responses were almost confined to active chronic hepatitis (53% abnormal), primary biliary cirrhosis (64%), and cryptogenic cirrhosis (29%). The test was also abnormal in five out of seven patients with jaundice due to drug hypersensitivity and in one patient with acute infectious hepatitis at a time when mitochondrial antibodies were present in the serum. More of those with active chronic hepatitis on prednisone or azathioprine had normal tests than of those who were untreated, and in 8 out of 10 examined serially during therapy there was an accompanying improvement in leucocyte migration. Abnormal responses to salivary gland or kidney antigens were also found in nearly half of those with features of Sjögren's syndrome or renal tubular acidosis as part of a multisystem involvement-this, though occurring in cryptogenic cirrhosis, was found with greater frequency in active chronic hepatitis and primary biliary cirrhosis. These cell-mediated immune responses, perhaps triggered by the initial damage to the liver from viral or other agents, may be responsible both for the perpetuation of the liver disease and, because of common surface antigens, for the damage to other organs.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5015047      PMCID: PMC1787446          DOI: 10.1136/bmj.1.5799.527

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Immunological and histological studies in primary biliary cirrhosis.

Authors:  S Hadziyannis; P J Scheuer; T Feizi; R Naccarato; D Doniach; S Sherlock
Journal:  J Clin Pathol       Date:  1970-03       Impact factor: 3.411

2.  Reaction of human smooth muscle antibody with liver cells.

Authors:  L J Farrow; E J Holborow; W D Brighton
Journal:  Gut       Date:  1971-06       Impact factor: 23.059

3.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

4.  Application of the leucocyte migration test to the diagnosis of rejection after liver transplantation.

Authors:  A L Eddleston; M G Smith; C G Mitchell; R Williams
Journal:  Transplantation       Date:  1971-07       Impact factor: 4.939

Review 5.  The concept of an 'autoallergic' hepatitis.

Authors:  D Doniach
Journal:  Proc R Soc Med       Date:  1970-05

6.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

7.  Anti-adrenal cellular hypersensitivity in Addison's disease. IV. In vivo and in vitro investigations on the mitochondrial fraction.

Authors:  J Nerup; V Andersen; G Bendixen
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

8.  Human lymphocyte migration as a parameter of hypersensitivity.

Authors:  M Soborg; G Bendixen
Journal:  Acta Med Scand       Date:  1967-02

9.  "Sicca complex" in liver disease.

Authors:  P L Golding; R Bown; A M Mason; E Taylor
Journal:  Br Med J       Date:  1970-11-07

10.  Renal tubular acidosis and autoimmune liver disease.

Authors:  P L Golding; A S Mason
Journal:  Gut       Date:  1971-02       Impact factor: 23.059

View more
  29 in total

1.  Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.

Authors:  K Thestrup-Pedersen; K Ladefoged; P Andersen
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

2.  T and B lymphocytes in patients with chronic active hepatitis (CAH).

Authors:  M Colombo; S J Vernace; F Paronetto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

Review 3.  The immunology of liver disorders.

Authors:  G Walker
Journal:  Proc R Soc Med       Date:  1974-06

4.  Immunological studies of Australia antigen carriers with and without liver diseases.

Authors:  J O Nielsen; V Reinicke; O Dietrichson; V Andersen; M Thomsen; E Andersen
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

5.  Leucocyte migration inhibition in liver disease.

Authors:  C Vergani; T Oldoni; N Dioguardi
Journal:  J Clin Pathol       Date:  1974-10       Impact factor: 3.411

6.  Immunological assessment of mice with chronic jaundice and runting induced by reovirus 3.

Authors:  M L Walters; N F Stanley; R L Dawkins; M P Alpers
Journal:  Br J Exp Pathol       Date:  1973-06

7.  Cell-mediated immune response in primary biliary cirrhosis to a protein fraction from human bile.

Authors:  A L Eddleston; I G McFarlane; C G Mitchell; W D Reed; R Williams
Journal:  Br Med J       Date:  1973-11-03

8.  Cellular immune responses to salivary antigens in autoimmune liver disease with sicca syndrome.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; C Funk; B Portmann; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

9.  Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.

Authors:  E Fernandez-Cruz; P Escartin; A Bootello; M Kreisler; J M Segovia de Arana
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

10.  Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.

Authors:  P Tolentino; C Jannuzzi; R Giacchino
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.